Thalamocortical projections to the auditory cortex (ACx), a brain region implicated in auditory hallucinations [1] [2] [3] [4] , have emerged as a circuit that is specifically disrupted 5 in mouse models of 22q11DS 6 . This disorder, the most common microdeletion syndrome in humans 7, 8 , is caused by a hemizygous microdeletion (1.5-3 Mb) on the long arm of chromosome 22 (ref. 9). 22q11DS is considered to be a leading genetic cause of schizophrenia [10] [11] [12] . Schizophrenia develops in 23-43% of individuals with 22q11DS [13] [14] [15] [16] [17] [18] , most of whom experience psychosis 19, 20 . Furthermore, 30-50% of individuals who do not have schizophrenia but have 22q11DS demonstrate subthreshold symptoms of psychosis 21 . Nonpsychotic behavioral abnormalities are present from early life in patients with 22q11DS 22,23 , but psychotic symptoms and schizophrenia are delayed; the median age of psychosis onset is 21 years 18, 24, 25 . In patients with schizophrenia, auditory hallucinations and other psychotic symptoms are similarly delayed until late adolescence or early adulthood 26, 27 , present in 60-90% of cases 28 , and often alleviated by treatment with antipsychotics that inhibit D2 dopamine receptors (DRD2s) 29, 30 . Given the germline occurrence of deleted genes in 22q11DS, it is unclear why the onset of positive symptoms is delayed.
Thalamocortical projections to the auditory cortex (ACx), a brain region implicated in auditory hallucinations [1] [2] [3] [4] , have emerged as a circuit that is specifically disrupted 5 in mouse models of 22q11DS 6 . This disorder, the most common microdeletion syndrome in humans 7, 8 , is caused by a hemizygous microdeletion (1.5-3 Mb) on the long arm of chromosome 22 (ref. 9) . 22q11DS is considered to be a leading genetic cause of schizophrenia [10] [11] [12] . Schizophrenia develops in 23-43% of individuals with 22q11DS [13] [14] [15] [16] [17] [18] , most of whom experience psychosis 19, 20 . Furthermore, 30-50% of individuals who do not have schizophrenia but have 22q11DS demonstrate subthreshold symptoms of psychosis 21 . Nonpsychotic behavioral abnormalities are present from early life in patients with 22q11DS 22, 23 , but psychotic symptoms and schizophrenia are delayed; the median age of psychosis onset is 21 years 18, 24, 25 . In patients with schizophrenia, auditory hallucinations and other psychotic symptoms are similarly delayed until late adolescence or early adulthood 26, 27 , present in 60-90% of cases 28 , and often alleviated by treatment with antipsychotics that inhibit D2 dopamine receptors (DRD2s) 29, 30 . Given the germline occurrence of deleted genes in 22q11DS, it is unclear why the onset of positive symptoms is delayed.
Recently, Dgcr8 emerged as a culprit gene responsible for several neuronal phenotypes in mouse models of 22q11DS 31, 32 , including the disruption of synaptic transmission at TC projections to the ACx 5 . Dgcr8 is part of the microprocessor complex that mediates the biogenesis of miRNAs, small RNAs that negatively regulate the stability of target mRNAs, as well as protein translation 33 . Dgcr8 haploinsufficiency in individuals with 22q11DS leads to depletion of miRNAs and the resultant upregulation of respective targets, which in turn disrupts synaptic transmission, synaptic plasticity, and proper functioning of neural circuits 34 . In adult mouse models of 22q11DS, Dgcr8 haploinsufficiency is sufficient to upregulate Drd2 mRNA and Drd2 protein in the auditory thalamus, causing auditory abnormalities that include decreased glutamatergic synaptic transmission at TC projections to the ACx and deficient prepulse inhibition (PPI) of the acoustic-startle response 5 . Abnormally high levels of Drd2 in the thalamus of 22q11DS mice increase TC projection sensitivity to Drd2 antagonists, including antipsychotics. Consequently, auditory synaptic and behavioral abnormalities of 22q11DS mice are rescued by treatment with antipsychotics 5 .
Here we tested whether TC disruption follows the same agedependent trajectory as psychosis in patients with 22q11DS or schizophrenia and determined the molecular underpinnings of TC disruption in 22q11DS mice.
RESULTS

Delayed disruption of TC synaptic transmission in mouse models of 22q11DS
We compared basal synaptic transmission in young (2-month-old) and mature (4-month-old) Df (16) 1/+ mice, a murine model of 22q11DS 6 (Fig. 1a) , and their wild-type (WT) littermates. Mice between the ages of 3 and 6 months correspond to mature human adults between the ages of 20 and 30 years 35 . Using whole-cell voltageclamp recordings, we measured TC excitatory postsynaptic currents (EPSCs) from thalamorecipient ACx cortical layer (L) 3/4 pyramidal neurons 36 while stimulating TC projections in acute brain slices containing the auditory thalamus (i.e., the ventral part of the medial geniculate nucleus (MGv)) and the ACx (Fig. 1b) . The input-output relationship between stimulation intensity and TC EPSC, a measure of basal synaptic transmission at TC projections, was deficient in older but not younger mutant mice as compared to that in WT controls (Fig. 1c,d) . Consistent with the notion that the increased amount of Drd2 in thalamic relay neurons reduces glutamatergic synaptic transmission at auditory TC projections in Df (16) 1/+ mice 5 , the Drd2 mRNA level was elevated in the MGv of older but not younger Df (16) 1/+ mice (Fig. 1e) .
Elevated Drd2 levels in older Df (16) 1/+ mice mediate the abnormal sensitivity of mutant TC projections to antipsychotics; thus, we tested the time course of this sensitivity at different ages of mice (1.5-7 months). In brief, we stimulated the thalamic radiation in brain slices of WT mice to evoke TC EPSCs with a rise slope of ~100 pA/ms. We compared the effect of the antipsychotic agent haloperidol (1 µM) on TC EPSC 30 min after its bath application to the preapplication baseline TC EPSC (∆H, a measure of haloperidol sensitivity). We determined that ∆H was significantly higher in Df (16) 1/+ mice than in WT littermates, but only beginning at 3 months of age ( Fig. 1f-h) . In older mice, a similar intensity of thalamic stimulation (Online Methods) evoked substantially smaller TC EPSCs in Df (16) 1/+ mice than in WT controls, and treatment with haloperidol rescued that deficit (Fig. 1g) . By contrast, TC projections in younger mutant mice were not sensitive to haloperidol treatment (Fig. 1f,h) .
Consistent with the notion that Dgcr8 haploinsufficiency underlies the TC deficiency in 22q11DS 5 , TC projections in Dgcr8 +/− mice older than 3 months were sensitive to haloperidol, whereas those in WT mice were not. TC projections in younger mice were not sensitive to haloperidol (Fig. 1i-k) . Drd2 mRNA levels were also elevated in the thalamus of only the older Dgcr8 +/− mice (Fig. 1l) . Furthermore, PPI, a measure of sensorimotor gating that is typically reduced in patients with schizophrenia 37, 38 , was deficient in older but not younger Dgcr8 +/− mice (Fig. 1m,n) . miR-338-3p mediates the disruption of TC synaptic transmission in 22q11DS Because Dgcr8 mediates miRNA processing 33 , we sought to identify the miRNA(s) mediating the Dgcr8-Drd2-dependent mechanism of TC deficiency. To this end, we performed miRNA microarray analysis of the auditory thalamus of 2-and 4-month-old mice (Supplementary Table 1 ). Among the miRNAs that potentially target the Drd2 transcript (on the basis of the miRWalk and TargetScan miRNA-targetprediction algorithms), only five miRNAs (miR-337-3p, miR-337-5p, miR-335-5p, miR-335-3p, and miR-338-3p) were depleted in the auditory thalamus of Df(16)1/+ or Dgcr8 +/− mice ( Fig. 2a-d) . Because miR-185, which is not a Drd2-targeting miRNA, is encoded within the Df(16)1 microdeletion, its depletion in Df(16)1/+ mice served as a positive control (Fig. 2a,b) . The qRT-PCR analysis verified that all five Drd2-targeting miRNAs were depleted in Dgcr8 +/− mice ( Supplementary Fig. 1a ). The expression of miRNAs decreased with age, regardless of genotype. The miRNA levels in older mice were lower than those in young WT or Dgcr8 +/− mice. However, because Dgcr8 haploinsufficiency depleted these miRNAs at both ages, the age-dependent decline in miRNA expression was exacerbated in mutants and reached minimal values at 4 months in Dgcr8 +/− mice (Supplementary Fig. 1a) . Of the five miRNAs predicted to target Drd2 overexpression, miR-337-3p, miR-337-5p, miR-335-3p, and miR-338-3p, but not miR-335-5p, decreased DRD2 mRNA in vitro in human SH-SY5Y cells (Supplementary Fig. 1b) .
To identify which of the miRNA(s) that target the Drd2 3′ untranslated region (UTR) (Fig. 2e) regulate the Dgcr8-Drd2-dependent mechanism of TC deficiency in vivo, we performed a screen based on the abnormal sensitivity of TC projections to haloperidol. We overexpressed mature miRNAs in excitatory thalamic neurons by injecting adeno-associated viruses (AAVs) encoding GFP and miR-337-5p, miR-338-3p, miR-335-5p, miR-337-3p, or miR-335-3p under the control of the promoter of the excitatory-neuron-specific gene Camk2a into the MGv of Df (16)1/+ and WT mice (Fig. 2f,g ). Overexpression of individual miRNAs in 4-month-old Df(16)1/+ mice not only replenished the depleted miRNA levels, but it also increased their levels to those greater than the levels in WT mice ( Supplementary Fig. 2a-e) . However, of the five miRNAs, only miR-338-3p overexpression rescued the abnormal haloperidol sensitivity observed in Df(16)1/+ mice ( Fig. 2h and Supplementary Fig. 2f-k) . Overexpression of miR-338-3p in the MGv of Df(16)1/+ mice decreased Drd2 mRNA levels in the MGv by 47.6 ± 10.2% as compared to those in the MGv treated with control virus (n = 6 mice for AAV-GFP-miR-338-3p; n = 6 mice for AAV-GFP; t (10) = 3.27, P = 0.008 by two-tailed t-test), confirming that miR-338-3p regulates Drd2 levels.
miR-338-3p, miR-335-3p, and miR-335-5p have conserved seed sites in the mouse and human Drd2 3′ UTR. Consistent with the notion that only abundant miRNAs effectively regulate the targeting transcript(s) 39 , miR-338-3p seemed to be more crucial for Drd2 regulation in the auditory thalamus than did miR-337-5p, miR-335-5p, miR-337-3p, or miR-335-3p. Indeed, miR-338-3p was enriched in the thalamus as compared to the other four miRNAs; miR-337-3p, miR-335-5p, miR-337-3p, and miR-335-3p levels were approximately 0-1% those of miR-338-3p (Fig. 2i) . Moreover, miR-338-3p was enriched in the thalamus as compared to other tested brain regions (Fig. 2i) , suggesting that depletion of this Drd2-regulating miRNA in subjects with 22q11DS mainly affects thalamic function. Similarly, miR-338-3p was enriched in the MGv as compared to the ACx (Brodmann area 41) in post-mortem tissue samples from human subjects (Fig. 2j and Supplementary Table 2) . Moreover, miR-338-3p levels were significantly decreased in the thalamus but not the ACx of patients with schizophrenia as compared to those in age-and sex-matched controls (Fig. 2j) . We previously showed that the DRD2 protein level is elevated in MGv samples 5 .
Replenishing miR-338-3p in the MGv rescues the TC deficits in 22q11DS mice To rescue the disruption of TC synaptic transmission in Df (16) 1/+ mice, we replenished miR-338-3p in the thalamic relay neurons by injecting AAV-GFP-miR-338-3p into the MGv in vivo, using an approach similar to that used in previous experiments (Fig. 2h) ; AAV-GFP was used as a control (Fig. 3a) . After 3 to 4 weeks, we found robust expression of GFP in the MGv neurons, and the GFP-labeled projections were clearly visible in the L3/4 thalamorecipient layer of the ACx (16) ( Fig. 3b) . We recorded the input-output relations at TC projections in 4-to 5-month-old WT and Df (16)1/+ mice that were injected with either AAV-GFP-miR-338-3p or AAV-GFP. As in previous experiments 5 ( Fig. 1d) , we observed a substantial deficit in TC synaptic transmission between WT and Df(16)/1+ mice that were injected with AAV-GFP. WT mice injected with AAV-GFP-miR-338-3p
did not show a significant increase in synaptic transmission as compared to control mice. However, the TC synaptic transmission deficit was rescued in Df (16)1/+ mice that were injected with AAV-GFPmiR-338-3p (Fig. 3c) . Similarly, the presynaptic TC deficit observed in Df (16) The number of cells recorded is shown in parentheses. *P < 0.01 by two-tailed t-test or Mann-Whitney rank-sum U test depending on whether data pass or fail the normality test. (i) Relative average levels of miRNAs in the thalamus, hippocampus, and cortex of WT mice (n = 5 mice for each brain region, run in triplicates). Data were normalized to the average expression of three housekeeping genes: Rnu6 (encoding U6 snRNA), Snord68, and Snord70. Only miR-338-3p shows enrichment in the thalamus. H (2) = 18.85, *P < 0.001. (j) Mean relative miR-338-3p levels (normalized to those of Rnu6) in the post-mortem MGv and ACx tissues from healthy controls and patients with schizophrenia (SCZ) (MGv: n = 7 controls; n = 7 patients; t (40) = 4.56; *P < 0.001; ACx: n = 8 controls; n = 8 patients; U = 278; P = 0.845; measured in triplicates). a deficient paired-pulse ratio (PPR) of two consecutive TC EPSCs in Df(16)1/+ mice without affecting TC PPR in WT mice at all of the measured interpulse intervals (Fig. 3d) . These results indicate that depletion of miR-338-3p is a necessary component for developing TC deficits in mouse models of 22q11DS.
miR-338-3p depletion in the MGv or Mir338 knockout recapitulates the auditory TC synaptic abnormalities of 22q11DS mice To test whether miR-338-3p depletion is sufficient to trigger TC deficits, we used two strategies. First, we constructed a miR-338-3p sponge by using a previously described strategy 40 . Second, we generated Mir338-knockout (KO) mice (Fig. 4) . The miR-338-3p sponge efficiency was verified in an in vitro system by using the luciferase assay. The sponge with 12 seed sites substantially and specifically depleted miR-338-3p levels in vitro (Supplementary Fig. 3 ). On the basis of these data, we constructed AAVs expressing either the miR-338-3p sponge or a scrambled control vector under the control of the Camk2a promoter (Fig. 4a ). An AAV expressing the miR-338-3p sponge injected into the MGv of WT mice was sufficient to increase levels of the Drd2 mRNA (Fig. 4b) and render the TC projections sensitive to haloperidol (Fig. 4c) .
We then generated a mutant mouse lacking Mir338 (Mir338-KO mice) (Fig. 4d) . The Mir338 locus is within the seventh intron of the apoptosis-associated tyrosine kinase (Aatk) gene. However, unlike miR-338-3p, Aatk expression in the MGv was not affected by age or Mir338 deletion (Supplementary Fig. 4a,b) . The Mir338-KO mice lacked miR-338-3p, miR-338-5p, and both miR-3065-3p and miR-3065-5p, whose genomic loci overlap with that of Mir338. However, miR-338-5p, miR-3065-3p, and miR-3065-5p were not Drd2-targeting miRNAs, as predicted by the miRNA-target-prediction algorithms, and their expression levels in the auditory thalamus were 0% to 2.5% that of miR-338-3p (Supplementary Fig. 4c ). The Mir338 +/− and Mir338 −/− mice developed normally (Supplementary Fig. 4d,e) . Their Drd2 RNA levels were inversely correlated with miR-338-3p levels in the auditory thalamus (Fig. 4e) . Moreover, Drd2 protein levels were elevated in the MGv but not in the cortex or hippocampus of the Mir338 +/− or Mir338 −/− mice (Fig. 4f) , further indicating that miR-338-3p regulates Drd2 expression in the auditory thalamus.
Because miR-338-3p is depleted but not eliminated in Df (16)1/+ mice, we tested TC synaptic properties in 4-month-old Mir338 +/− mice. Similar to that observed in Df(16)1/+ mice 5 , synaptic transmission at TC projections was substantially disrupted in Mir338 +/− mice. The input-output function, which we tested by electrical stimulation of TC projections, showed a decrease in TC EPSCs in Mir338 +/− mice as compared to that in WT mice (Fig. 4g,h ). This disruption was specific to TC projections. The input-output function tested by electrical stimulation of corticocortical (CC) projections in the same slices did not differ between Mir338 +/− and WT mice (Fig. 4i) . The PPR of two consecutive electrically evoked EPSCs was substantially altered in TC but not CC projections of Mir338 +/− mice as compared to that in WT controls (Fig. 4j,k) . By contrast, the ratio of NMDA-receptormediated current to AMPA-receptor-mediated current (NMDAR/ AMPAR ratio, a measure of the postsynaptic function) was normal in both TC and CC projections of Mir338 +/− mice (Fig. 4l,m) . Because electrical stimulation of the thalamic radiation may affect circuits other than TC projections 41 , we activated TC projections more selectively by using the optogenetic approach. To that end, we injected AAVs expressing the light-activated cation channel channelrhodopsin 2 (ChR2) under the control of Camk2a promoter into the MGv of Mir338 +/− and WT littermates. We then activated TC projections by using 473-nm light pulses (Fig. 4n) . The input-output relations and PPR (but not the NMDAR/AMPAR ratio) of optically evoked EPSCs were substantially decreased in 4-month-old Mir338 +/− mice as compared to those in WT littermates ( Fig. 4o-q) , which recapitulated the TC disruption in mouse models of 22q11DS.
Mir338 haploinsufficiency disrupts TC transmission by decreasing the glutamate-release probability of thalamic projections We previously showed that the TC disruption of synaptic plasticity in mouse models of 22q11DS was due to defective presynaptic function, which was in turn caused by the reduced probability of glutamate release from thalamic projections 5 . Abnormalities in the input-output relation and PPR at TC projections of Mir338 +/− mice also suggested a deficit in presynaptic function at TC glutamatergic synapses. To understand the nature of this deficit, we performed two-photon calcium imaging in dendritic spines, which are the inputs of thalamic projections on thalamorecipient neurons in the ACx. We loaded L3/4 pyramidal neurons with the calcium indicator Fluo-5F and cytoplasmic dye Alexa 594 (Fig. 5a ) and identified dendritic spines that responded to electrical stimulation of the thalamic radiation (Fig. 5b) . This method enabled us to measure three factors that may contribute to the TC disruption: the distribution of synaptic inputs on dendritic trees of postsynaptic neurons, the amplitudes of calcium transients, and the probability of calcium transients at individual dendritic spines (a proxy for the probability of neurotransmitter release measured at a single synaptic input) 42, 43 . The distribution of active TC inputs on dendritic trees and the peak amplitudes of postsynaptic calcium transients in Mir338 +/− mice were comparable to those in WT mice (Fig. 5c-e) , suggesting that TC development, pathfinding, synaptic targeting of cortical neurons by TC projections, and postsynaptic glutamatergic receptor function were not compromised in Mir338 +/− mice. Although this negative result shows the lack of a deficit in TC morphology, it does not rule out potential morphological deficits on a finer subsynaptic scale. Notably, the probability of calcium transients in dendritic spines of thalamorecipient neurons in response to a lowfrequency (0.1 Hz) train of stimuli was deficient in Mir338 +/− mice (Fig. 5f) . This result indicates that the depletion of miR-338 decreased the probability of glutamate release at TC projections, which underlies the TC disruption in individuals with 22q11DS. This deficit in the probability of glutamate release was rescued in slices that were treated with haloperidol (Fig. 5f) . Haloperidol treatment also effectively rescued the deficit in the probability of glutamate release in the same dendritic spine. The probability of detecting the calcium transient increased in Mir338 +/− (but not WT) dendritic spines after haloperidol application (Fig. 5g,h ). This finding further demonstrates that haloperidol rescues the presynaptic deficit of TC synaptic transmission in Mir338 KO mice.
Mir338 deletion or miR-338-3p depletion eliminate the age dependency of TC disruption and PPI The deletion of Mir338 was sufficient to upregulate Drd2 expression in the thalamus, which suggested that depletion of only miR-338-3p underlies the abnormal sensitivity of TC projections in individuals with 22q11DS to treatment with antipsychotics. To test this hypothesis, we compared the sensitivity of TC projections in Mir338 +/− mice and WT mice. First, we determined that TC projections of Mir338 +/− (but not WT) mice were sensitive to the Drd2-specific antagonist L-741,626 (20 nM) (Fig. 6a) . In Mir338 +/− mice, TC EPSCs substantially increased in response to L-741,626, but that increase was not further elevated by application of haloperidol. Treatment with haloperidol alone increased TC EPSCs in 4-month-old Mir338 +/− (but not in WT) mice to magnitudes similar to those observed in Df(16)1/+ or Dgcr8 +/− mice, suggesting that haloperidol's effect in mutant TC projections was mediated by elevated expression of Drd2 receptors ( Fig. 6b and Supplementary Fig. 5) . Similarly, treatment with other antipsychotics (such as clozapine and olanzapine) increased TC EPSCs to magnitudes similar to those seen in Mir338 +/− but not WT mice (Supplementary Fig. 6 ).
Unlike Df (16)1/+ or Dgcr8 +/− mice, Mir338 +/− mice became sensitive to haloperidol treatment in an age-independent manner ( Fig. 6b  and Supplementary Fig. 5 ). Furthermore, in young (2-month-old) WT mice, TC projections became sensitive to haloperidol when the miR-338-3p sponge was expressed in the MGv ( Supplementary  Fig. 7) , indicating that depletion of miR-338-3p in the MGv is sufficient for sensitivity to antipsychotics. TC sensitivity to haloperidol in 2-month-old Mir338 +/− mice was eliminated by expression of small interfering RNA (siRNA) specific for Drd2 (but not a control siRNA) in the MGv (Fig. 6c,d) . The specificity of the Drd2-specific siRNA has been characterized previously 5 . These experiments further indicated that miR-338-3p is sufficient to regulate Drd2 in the thalamus, regardless of age. Similarly, Mir338 +/− mice were deficient in PPI as compared to WT control mice, and this deficit was observed at all of the time points tested (1.5, 2, and 4 months) (Fig. 6e-g ). The defect in PPI was not caused by peripheral hearing defects because the acoustic-brainstem-response testing showed no differences between Mir338 +/− and WT mice at these ages (Supplementary Fig. 8 ).
DISCUSSION
The recent identification of disrupted glutamatergic synaptic transmission at thalamic inputs to the ACx in 22q11DS mice 5 suggests that TC disruption could be a pathogenic mechanism that mediates the susceptibility to positive psychotic symptoms in 22q11DS-related schizophrenia for the following reasons. (i) TC disruption in 22q11DS mice is rescued by treatment with antipsychotic medications that are Drd2 antagonists and that effectively treat predominantly psychotic symptoms but substantially less effectively treat cognitive or negative symptoms of schizophrenia [44] [45] [46] . This disruption was specific to auditory TC projections and not observed at other glutamatergic projections (i.e., hippocampal, corticocortical, or corticofugal projections) that may be involved in cognitive, social, or motivational tasks.
(ii) TC disruption in 22q11DS mice is caused by abnormal elevation of Drd2 mRNA and Drd2 protein levels in the thalamus, a brain region previously linked to psychotic symptoms of schizophrenia 47, 48 . The increase in dopamine signaling in the thalamus was also described in patients with schizophrenia 49 , and studies have indicated that drug-naive patients with schizophrenia have elevated levels of DRD2s in other brain regions 50, 51 . Furthermore, theoretical and empirical studies have proposed that deficient connectivity and abnormal patterns of activity in TC projections contribute to the pathogenesis of the disease [52] [53] [54] [55] . Moreover, a local ischemic infarction that disrupts auditory TC projections in a patient without psychosis can cause (2) haloperidol in 2-month-old WT (control siRNA, n = 10 neurons; Drd2-specific siRNA, n = 9 neurons) and Mir338 +/− control siRNA, n = 14 neurons; Drd2-specific siRNA, n = 10 neurons) mice that received control (c) or Drd2-specific siRNA (d) injected into their MGv. Insets show representative EPSCs. In a-d, data are represented as the mean ± s.e.m. (e-g) Mean PPI of maximal acoustic-startle response in 1.5-month-old (e), 2-month-old (f), and 4-month-old (g) WT (22, 22 , and 21 mice, respectively) and Mir338 +/− littermates (21, 21, and 20 mice, respectively). In e, F (5) = 21.648, *P < 0.001; in f, H (5) = 39.887, *P < 0.001; in g, H (5) = 17.348, *P = 0.004. SPL, sound pressure level. (h) Model of TC disruption in individuals with 22q11DS. DGCR8-dependent depletion of the thalamus-enriched miR-338-3p leads to an increase in DRD2 levels in the auditory thalamus (MGv) and disruption of thalamocortical synaptic transmission to the auditory cortex (ACx) later in life. The red cross (X) represents disruption of synaptic transmission in TC projections.
auditory hallucinations 56 . (iii) Abnormal sensitivity to antipsychotics is observed in the auditory but not the visual or somatosensory TC projections of 22q11DS mice 5 , which is consistent with clinical observations of the substantially higher prevalence of auditory hallucinations, as compared to the hallucinations observed in other sensory modalities, in individuals with schizophrenia 28 . Neuroimaging and electrophysiological studies in patients with schizophrenia have shown abnormal activation of the auditory thalamus and the ACx during auditory hallucinations 1, 3, 21 . (iv) An increase in Drd2 levels only in the auditory thalamus of 22q11DS mice was sufficient to reduce the PPI of the acoustic-startle response 5 , the behavioral endophenotype characteristic of patients with psychiatric diseases, including 22q11DS and schizophrenia 38, 57 .
Here we showed that the disruption of synaptic transmission at auditory TC projections recapitulates another prominent feature of psychotic symptoms. The TC disruption in 22q11DS mice becomes evident only after 3 months of age, which is equivalent to ~20 years of age in humans 35 . These data correspond well with the age of onset of clinical manifestations of psychosis in patients with 22q11DS (median age, 21 years) 25 or schizophrenia during late adolescence or early adulthood, which is typically between the ages of 16 and 30 years 26, 58 . This age-dependent TC decrease in synaptic function is evident in Df(16)1/+ mice, which carry a large microdeletion, and in Dgcr8 +/− mice, further strengthening the case that Dgcr8 is the culprit gene and that its haploinsufficiency underlies auditory abnormalities in individuals with 22q11DS.
Previous work established that the deletion of one copy of Dgcr8 leads to increased levels of Drd2 in the auditory thalamus 5 . Because Dgcr8 is part of the miRNA-processing machinery, we hypothesized that a Dgcr8-miRNA-Drd2 mechanism underlies the disruption of TC synaptic transmission. Here we identified miR-338-3p as the mediator of this mechanism (Fig. 6h) . We also showed that miR-338-3p negatively regulates the level of Drd2 in the thalamus. Replenishing miR-338-3p in the thalamus eliminates deficient TC synaptic transmission and abnormal antipsychotic sensitivity of TC projections in 22q11DS mice, and the deletion of Mir338 or auditory-thalamus-specific knockdown of miR-338-3p expression mimics TC disruption of synaptic transmission and antipsychotic sensitivity in WT mice. Depletion of miR-338-3p is therefore necessary and sufficient to upregulate Drd2 in the thalamus, which in turn reduces glutamate release from thalamic projections, reduces TC synaptic transmission, and renders TC projections sensitive to antipsychotics (Fig. 6h) . Because miR-338-3p is enriched in the auditory thalamus and more abundant miRNAs more effectively regulate the targeting transcripts 39 , miR-338-3p reduction in the thalamus (but not in tissues where it is weakly expressed) would upregulate thalamic Drd2 and provide tissue specificity.
TC disruption in 22q11DS mice and Mir338-deficient mice correlates with deficits in PPI, an impaired sensorimotor gating feature that occurs in individuals with schizophrenia and several other neuropsychiatric disorders. The importance of the auditory thalamus for PPI is well known 59 , but the effect of disrupting TC projections on PPI deficits is not. Therefore, other projections emanating from the auditory thalamus and containing depleted miR-338-3p and upregulated Drd2 might cause PPI deficits in 22q11DS mice.
One copy of Dgcr8 is deleted in individuals with 22q11DS, in all cells at all ages, so it is unclear why synaptic disruption occurs in projections emanating only from the thalamus and only later in life. The regional specificity most likely arises from the fact that miR-338-3p is substantially enriched in the auditory thalamus as compared to other brain regions, such as the cortex or hippocampus. Explaining why miR-338-3p is thalamus-enriched will require further investigation. We also determined that the expression of miR-338-3p is regulated in an age-dependent manner. Although miR-338-3p is depleted in the auditory thalamus in 22q11DS mice at all ages, as compared to WT mice, it declines further with age in both 22q11DS and WT mice. Therefore, miR-338-3p expression may be controlled by a combination of Dgcr8-and age-dependent mechanisms. Although we can assume that Dgcr8 haploinsufficiency reduced the levels of miRNAs, the mechanism of age-dependent miRNA decline is unknown. In the context of Drd2 regulation, a minimal threshold of miR-338-3p expression probably triggers the overexpression of Drd2. In WT mice, miR-338-3p expression declines during the first few months of life, but it may not reach that threshold. However, in 22q11DS mice, a combination of Dgcr8 haploinsufficiency and age-dependent decline in miRNA production drives the miR-338-3p level below this threshold, triggers the increase in Drd2 levels in the thalamus, and causes TC synaptic and behavioral deficiencies.
In summary, our data implicate thalamus-enriched miR-338-3p as the key mediator of the disruption of synaptic transmission at TC projections and the late onset of auditory symptoms in individuals with 22q11DS. Our data also suggest that replenishment of miR-338-3p in the thalamus could be a more tolerable therapeutic approach for positive symptoms. Current therapy relies on antipsychotics to alleviate psychosis in patients with schizophrenia through the systemic inhibition of DRD2, which is accompanied by multiple, and sometimes devastating, side effects 27, 60 . Given that the seed sites of miR-338-3p are conserved between humans and mice and that miR-338-3p is enriched in the thalamus of both species and becomes depleted in the thalamus of mouse models of 22q11DS and of patients with schizophrenia, this strategy is potentially applicable to patients. Thus, our results suggest that miR-338-3p is a potential therapeutic target for treating positive symptoms of 22q11DS and related cases of schizophrenia.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Animals.
Mice of both sexes were used for all experiments. Df(16)1/+ and Dgcr8 +/− mouse strains were reported previously 6, 31 and were backcrossed onto the C57BL/6J genetic background for at least ten generations. Mice ranging in age from 1.5 to 7 months were used, which approximately corresponds to 13 to 35 years of age in humans 35 (https://www.jax.org/research-and-faculty/ research-labs/the-harrison-lab/gerontology/life-span-as-a-biomarker). The Mir338 +/− and Mir338 −/− mice were generated from embryonic stem cells from C57BL/6N-A tm1Brd mice that were purchased from the Mutant Mouse Regional Resource Center (MMRRC; clone #034476-UCD). These cells were tested and found to be negative for mycoplasma contamination. C57BL/6 blastocyst injections were performed by the Transgenic/Gene Knockout Shared Resource at St. Jude Children's Research Hospital (St. Jude). Chimeric mice were genotyped according to MMRRC protocols by using the following primers: 5′ common reverse (ATAGCATACATTATACGAAGTTATCACTGG), 5′ gene-specific (CTTCACTACACTCTCCCTAGTACAGTCTC), 3′ common forward (TCTAGAAAGTATAGGAACTTCCATGGTC), and 3′ gene-specific (AGGAGACTCATAGTTCTCTGTATCATAGC). PCR was performed under the following conditions: 93 °C for 3 min, 93 °C for 15 s, and 68 °C for 9 min for 8 cycles, and then 93 °C for 15 s, 60 °C for 30 s, and 68 °C for 9 min for 32 cycles. The mutant allele generated a 6.1-kb band with the 5′ commonreverse and 5′ gene-specific primers and a 4.1-kb band with the 3′ commonforward and 3′ gene-specific primers. The wild-type (WT) allele did not generate a band with either primer set. Subsequent genotyping was performed at Transnetyx (Cordova, Tennessee). For the majority of experiments, mice were divided into groups according to genotype or viral injections, and the experimenters were blinded to the genotype or treatment. The care and use of animals were reviewed and approved by the St. Jude Institutional Animal Care and Use Committee.
Whole-cell electrophysiology. Acute primary thalamocortical (TC) slices (400-µm thick) containing the left auditory cortex (ACx) and the left ventral part of the medial geniculate nucleus (MGv) of the thalamus were prepared as previously described 5, 61 . Briefly, mouse brains were quickly removed and placed in cold (4 °C) dissecting artificial cerebrospinal fluid (ACSF) containing 125 mM choline chloride, 2.5 mM KCl, 0.4 mM CaCl 2 , 6 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , and 20 mM glucose (300-310 mOsm), with 95% O 2 and 5% CO 2 . Primary TC slices were obtained from the left hemisphere by using a slicing angle of 15°. After a 1-h incubation in ACSF (125 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 20 mM glucose (300-310 mOsm), with 95% O 2 and 5% CO 2 ) at room temperature, the slices were transferred into the recording chamber and superfused (2-3 mL/min) with warm (30-32 °C) ACSF.
Whole-cell recordings were obtained from cell bodies of layer (L) 3/4 thalamorecipient neurons in the ACx. Mice were chosen in a pseudorandom order, without the experimenter's prior knowledge of genotype or treatments.
Patch pipettes (open-pipette resistance, 3.5-5.0 MΩ) were filled with an internal solution containing 125 mM CsMeSO 3 , 2 mM CsCl, 10 mM HEPES, 0.1 mM EGTA, 4 mM MgATP, 0.3 mM NaGTP, 10 mM Na 2 creatine phosphate, 5 mM QX-314, 5 mM tetraethylammonium chloride (pH 7.4 adjusted with CsOH; 290-295 mOsm). Voltage-clamp recordings were made using a Multiclamp 700B, digitized (10 kHz), and recorded using the pCLAMP 10.0 software (Molecular Devices). Excitatory postsynaptic currents (EPSCs) were recorded at holding membrane potentials of −70 mV. In all experiments, membrane potentials were corrected for a liquid junction potential of −10 mV. TC EPSCs were evoked by current pulses (duration, 100 µs) delivered to the thalamic radiation via tungsten bipolar electrodes. The stimulation intensities were similar in experiments in Paired-pulse ratio (PPR) of TC and corticocortical (CC) EPSCs and the NMDAR/AMPAR ratio were measured as described previously 5 . The first 2 ms of the EPSC slope were measured as an accurate indicator of monosynaptic strength at TC synapses 62 . Changes in the EPSC slope correlated with changes in the EPSC amplitude and EPSC charge 5 . To ensure consistent access resistance of the recording electrode during long-term experiments, we monitored the peak amplitude of a brief (10-ms) hyperpolarizing test pulse (−5 mV), which was given 250 ms after a stimulus. Access resistance in recorded neurons was typically 10 to 25 MΩ. Recordings were discarded if the access resistance was higher than 25 MΩ, or if it changed more than 15% during the course of the whole-cell recording.
Two-photon imaging. Two-photon laser-scanning microscopy was performed using an Ultima imaging system, a Ti:sapphire Chameleon Ultra femtosecond-pulsed laser, and 60× (0.9 numerical aperture) water-immersion infrared objectives. Synaptically evoked calcium transients were measured in dendritic spines, the site of thalamic inputs, as described previously 43 . Briefly, Alexa Fluor 594 (30 µM) and Fluo-5F (300 µM) were included in the internal pipette solution (see above) and were excited at 820 nm. Synaptically evoked changes in fluorescence of both fluorophores were measured in the line-scan mode (750 Hz) in spine heads and the parent dendritic shaft. Line scans were analyzed as changes in green (G, Fluo-5F) fluorescence normalized to red (R, Alexa Fluor 594) fluorescence (∆G/R). The amplitude and probability of calcium transients were measured in response to 10 to 20 stimulations delivered at 0.1 Hz to the thalamic radiation. Distance (angular) of the active thalamic inputs from the center of the soma was calculated by using maximum-intensity projections of z-scan images of the entire cell collected at lower magnification.
Optogenetics.
In optogenetic experiments, we expressed the light-activated cation channel ChR2 in the MGv by using adeno-associated virus (AAV) and evoked optically induced EPSCs by briefly illuminating TC slices with a 473-nm light 63 . AAVs were generated from the pAAV-Camk2a-hChR2(H134R)-YFP-WPRE-pA (which we refer to as CamKIIα-ChR2-YFP) plasmid and produced commercially (UNC Vector; serotype 2/1; 4 × 10 12 infectious units per mL). AAVs were injected into the MGv as described previously 41 . Adult mice were anesthetized with isoflurane in pure oxygen, and a 200-to 400-nL sample of virus was slowly pressure-injected into the MGv (from the bregma: anterior-posterior, −3.0 mm; medial-lateral, ± 2.0 mm; dorsal-ventral, 3.1 mm). Approximately 21-28 d after virus injection, the mice were decapitated, and TC slices were prepared. Confocal imaging of YFP in the MGv was used to verify on-target infection of CamKIIα-ChR2-YFP viruses. Short light pulses (10-200 mW) from a 473-nm laser were directed to the slices through the visible light photoactivation module or through the objective. miRNA microarray. Total RNA was isolated from the thalami containing MGv of 2-and 4-month-old male WT, Df(16)1/+, and Dgcr8 +/− mice by using the mirVana RNA isolation kit (Life Technologies, Carlsbad, CA). Total RNAs (100 ng) were labeled using the miRNA Complete Labeling and Hyb Kit (Agilent, Santa Clara, CA), followed by hybridizing to the Mouse miRNA v19 Microarray (Agilent-046065) that contains 3,105 unique probes targeting 1,247 mature miRNAs, according to the mouse miRBase version 19.0 (http://www.mirbase. org; August 2012). Microarrays were scanned using an Agilent array scanner (G2565CA) at 3-µm resolution. Microarray data were extracted by Agilent Feature Extraction software (v.10.5.1.1) with the miRNA_107_Sep09 protocol. The data process was performed using Partek software (St. Louis, MO).
After quantile normalization among arrays, each probe was summarized by averaging intensities with a single normalized intensity value. The Student's t-test was used to determine statistical significance between sets of replicates from different experimental groups. The miRNA was considered significantly differentially expressed when the P value was less than 0.01 for more than one probe targeting the mature form of the miRNA. The mRNAs targeted by differentially expressed miRNAs were predicted using bioinformatics tools miRWalk 64 and TargetScan (http://www.targetscan.org).
Quantitative RT-PCR. Total RNA was isolated from various brain regions (i.e., the auditory thalamus containing the MGv, hippocampus, or cortex) or from SH-SY5Y cells (ATCC, CRL-2266) by using the mirVana RNA Isolation Kit (Life Technologies). The iScript kit (Bio-Rad, Hercules, California) was used to synthesize cDNA from mRNA, and the miRNA First-Strand cDNA Synthesis
